The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Association between the Current Use of Low-Dose Oral Contraceptives and Cardiovascular Arterial Disease: A Meta-Analysis
Abstract
CONTEXT: The long-term cardiovascular safety of widely used oral contraceptives (OCs) is still debated, and no meta-analysis assesses the modern use of OCs and the associated cardiovascular risks. OBJECTIVE: We aimed to assess the risk of cardiovascular diseases associated with current use of low-dose combined OCs. DATA SOURCES: All studies published between January 1980 and October 2002 were searched using MEDLINE, BIOSIS, and Scientific Citations. STUDY SELECTION: Original studies were selected independently by two investigators (J.P.B., P.A.E.) based on inclusion criteria: low-dose combined OC (<50 mug of ethinyl-estradiol); more than 10 cases in low-dose users; clear definition of cases; concurrent controls; and control for age. A third investigator (J.E.N.) adjudicated disagreements. From 2715 identified articles, 14 independent studies were included. DATA EXTRACTION: All data were abstracted by one investigator (J.P.B.) in a systematic manner. Classification of OCs and types of exposure were directly abstracted from studies. Current use was defined as use at the time of the event or within 3 months. Only peer-reviewed studies with definition of events as definite or possible, based on prespecified criteria, were included. DATA SYNTHESIS: The summary risk estimates associated with current use of low-dose OCs were 1.84 [95% confidence interval (CI) = 1.38, 2.44] for myocardial infarctions and 2.12 (95% CI = 1.56, 2.86) for ischemic strokes. The overall summary odds ratio for both outcomes was 2.01 (95% CI = 1.63, 2.48). Second generation OCs were associated with a significant increased risk of both myocardial infarction and ischemic stroke events [1.85 (95% CI = 1.03,3.32) and 2.54 (95% CI = 1.96,3.28), respectively]; and third-generation OCs, for ischemic stroke outcome only [2.03 (95% CI = 1.15,3.57)]. CONCLUSIONS: In conclusion, a rigorous meta-analysis of the literature suggests that current use of low-dose OCs significantly increases the risk of both cardiac and vascular arterial events, including a significant risk of vascular arterial complications with third generation OCs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
International diagnostic criteria for acute myocardial infarction and acute stroke
Gillum, R. F., Fortmann, S. P., Prineas, R. J., & Kottke, T. E. (1984) · American Heart Journal · doi:10.1016/0002-8703(84)90558-1 · Cited by 484
Third generation oral contraceptives and risk of venous thrombosis: meta-analysis
Kemmeren, J. M., Algra, A., & Grobbee, D. E. (2001) · BMJ · doi:10.1136/bmj.323.7305.131 · Cited by 455
Ischemic Stroke Risk With Oral Contraceptives: A Meta-analysis
Gillum, L. A., Mamidipudi, S. K., & Johnston, S. C. (2000) · JAMA · doi:10.1001/jama.284.1.72 · Cited by 402
Drospirenone: pharmacology and pharmacokinetics of a unique progestogen
Krattenmacher, R. (2000) · Contraception · doi:10.1016/s0010-7824(00)00133-5 · Cited by 376
(1996) · The Lancet · doi:10.1016/s0140-6736(95)12393-8 · Cited by 334
Stroke in Users of Low-Dose Oral Contraceptives
Petitti, D. B., Sidney, S., Bernstein, A., Wolf, S., Quesenberry, C., & Ziel, H. K. (1996) · New England Journal of Medicine · doi:10.1056/nejm199607043350102 · Cited by 329
Combination Estrogen–Progestin Oral Contraceptives
Petitti, D. B. (2003) · New England Journal of Medicine · doi:10.1056/nejmcp030751 · Cited by 242
Oral Contraceptives and the Risk of Myocardial Infarction
Tanis, B. C., van den Bosch, M. A. A. J., Kemmeren, J. M., Cats, V. M., Helmerhorst, F. M., Algra, A., van der Graaf, Y., & Rosendaal, F. R. (2002) · Obstetrical and Gynecological Survey · doi:10.1097/00006254-200205000-00021 · Cited by 225
Kemmeren, J. M., Tanis, B. C., van den Bosch, M. A. A. J., Bollen, E. L. E. M., Helmerhorst, F. M., van der Graaf, Y., Rosendaal, F. R., & Algra, A. (2002) · Stroke · doi:10.1161/01.str.0000015345.61324.3f · Cited by 222
Cited by
(2013) · European Heart Journal · doi:10.1093/eurheartj/eht151 · Cited by 13,655
Mancia, G., Fagard, R., Narkiewicz, K., Redón, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Journal of Hypertension · doi:10.1097/01.hjh.0000431740.32696.cc · Cited by 5,655
Meschia, J. F., Bushnell, C., Boden-Albala, B., Braun, L. T., Bravata, D. M., Chaturvedi, S., Creager, M. A., Eckel, R. H., Elkind, M. S. V., Fornage, M., et al. (2014) · Stroke · doi:10.1161/str.0000000000000046 · Cited by 2,650
Goldstein, L. B., Bushnell, C. D., Adams, R. J., Appel, L. J., Braun, L. T., Chaturvedi, S., Creager, M. A., Culebras, A., Eckel, R. H., Hart, R. G., et al. (2011) · Stroke · doi:10.1161/str.0b013e3181fcb238 · Cited by 1,306
Bushnell, C., McCullough, L. D., Awad, I. A., Chireau, M. V., Fedder, W. N., Furie, K. L., Howard, V. J., Lichtman, J. H., Lisabeth, L. D., Piña, I. L., et al. (2014) · Stroke · doi:10.1161/01.str.0000442009.06663.48 · Cited by 941
Daskalopoulou, S. S., Rabi, D. M., Zarnke, K. B., Dasgupta, K., Nerenberg, K., Cloutier, L., Gelfer, M., Lamarre-Cliche, M., Milot, A., Bolli, P., et al. (2015) · Canadian Journal of Cardiology · doi:10.1016/j.cjca.2015.02.016 · Cited by 684
The polycystic ovary syndrome: a position statement from the European Society of Endocrinology
Conway, G., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Franks, S., Gambineri, A., Kelestimur, F., Macut, D., Micic, D., Pasquali, R., et al. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0253 · Cited by 676
Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak, A., et al. (2013) · Blood Pressure · doi:10.3109/08037051.2013.812549 · Cited by 426
Ischaemic stroke in young adults: risk factors and long-term consequences
Maaijwee, N. A. M. M., Rutten-Jacobs, L. C. A., Schaapsmeerders, P., van Dijk, E. J., & de Leeuw, F.-E. (2014) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.72 · Cited by 377
V Diretrizes Brasileiras de Hipertensão Arterial
(2007) · Arquivos Brasileiros de Cardiologia · doi:10.1590/s0066-782x2007001500012 · Cited by 351
Poly Cystic Ovarian Syndrome: An Updated Overview
El Hayek, S., Bitar, L., Hamdar, L. H., Mirza, F. G., & Daoud, G. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00124 · Cited by 323
Metformin for the treatment of the polycystic ovary syndrome
Nestler, J. E. (2008) · New England Journal of Medicine · doi:10.1056/nejmct0707092 · Cited by 313
Self-citationCombined oral contraceptives: the risk of myocardial infarction and ischemic stroke
Roach, R. E. J., Helmerhorst, F. M., Lijfering, W. M., Stijnen, T., Algra, A., & Dekkers, O. M. (2015) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011054.pub2 · Cited by 299
Aetiological diagnosis of ischaemic stroke in young adults
Ferro, J. M., Massaro, A. R., & Mas, J.-L. (2010) · The Lancet Neurology · doi:10.1016/s1474-4422(10)70251-9 · Cited by 277
Migraine in women: the role of hormones and their impact on vascular diseases
Sacco, S., Ricci, S., Degan, D., & Carolei, A. (2012) · The Journal of Headache and Pain · doi:10.1007/s10194-012-0424-y · Cited by 272
Turgeon, J. L., Carr, M. C., Maki, P. M., Mendelsohn, M. E., & Wise, P. M. (2006) · Endocrine Reviews · doi:10.1210/er.2005-0020 · Cited by 264
Stanczyk, F. Z., Archer, D. F., & Bhavnani, B. R. (2013) · Contraception · doi:10.1016/j.contraception.2012.12.011 · Cited by 201
“Stroke and myocardial infarction resulting from arterial thromboembolic events Although COCs increase the risk of ischemic stroke [197,198] and MI [197], their risk may be overestimated due to underlying disease such as hypertension or to smoking rather than COC use alone [199,200].”
BackgroundÅgren, U. M., Anttila, M., Mäenpää-Liukko, K., Rantala, M.-L., Rautiainen, H., Sommer, W. F., & Mommers, E. (2011) · The European Journal of Contraception & Reproductive Health Care · doi:10.3109/13625187.2011.604450 · Cited by 130
Gallagher, L. G., Davis, L. B., Ray, R. M., Psaty, B. M., Gao, D. L., Checkoway, H., & Thomas, D. B. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr134 · Cited by 121
Nader, S., & Diamanti-Kandarakis, E. (2007) · Human Reproduction · doi:10.1093/humrep/del407 · Cited by 109
Piltonen, T., Puurunen, J., Hedberg, P., Ruokonen, A., Mutt, S. J., Herzig, K. H., Nissinen, A., Morin-Papunen, L., & Tapanainen, J. S. (2012) · Human Reproduction · doi:10.1093/humrep/des225 · Cited by 94
Xu, Z., Li, Y., Tang, S., Huang, X., & Chen, T. (2015) · Thrombosis Research · doi:10.1016/j.thromres.2015.04.021 · Cited by 80
“Another meta-analysis [42] of studies from 1980 to 2002 limited to low-dose combined OCPs (second and third generation) showed an increased risk of ischemic stroke with OCP use (OR, 2.”
BackgroundMorin-Papunen, L., Martikainen, H., McCarthy, M. I., Franks, S., Sovio, U., Hartikainen, A.-L., Ruokonen, A., Leinonen, M., Laitinen, J., Järvelin, M.-R., et al. (2008) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2008.04.013 · Cited by 78
PCOS in Adolescence and Type 2 Diabetes
Carreau, A.-M., & Baillargeon, J.-P. (2015) · Current Diabetes Reports · doi:10.1007/s11892-014-0564-3 · Cited by 40
Self-citationNovel effects of hormonal contraceptive use on the plasma proteome
Josse, A. R., Garcia-Bailo, B., Fischer, K., & El-Sohemy, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045162 · Cited by 35
“Given that HC use has been shown to increase the risk of cardiometabolic [9–15] and vascular disease (thromboembolism and stroke) [6,7] and decrease the risk of certain cancers [2,3], it is important to explore potential links between new and emerging disease risk biomarkers and HC use.”
Background
Metadata
- Authors
- Baillargeon, J.-P., McClish, D. K., Essah, P. A., & Nestler, J. E.
- Venue
- The Journal of Clinical Endocrinology & Metabolism
- Publisher
- The Endocrine Society
- Published
- 2005-07
- Volume
- 90
- Issue
- 7
- Pages
- 3863-3870
- ISSN
- 0021-972X (ISSN-L)
- 1945-7197
- OpenAlex
- W1998181443
- Cited by
- 297
- References
- 33
- FWCI
- 16.17
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.